Compare CMPX & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPX | UVSP |
|---|---|---|
| Founded | 2014 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.5M | 983.8M |
| IPO Year | 2020 | 1994 |
| Metric | CMPX | UVSP |
|---|---|---|
| Price | $1.94 | $37.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | $15.83 | ★ $36.67 |
| AVG Volume (30 Days) | ★ 7.9M | 183.7K |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | N/A | ★ 21.32 |
| EPS | N/A | ★ 3.13 |
| Revenue | N/A | ★ $328,056,000.00 |
| Revenue This Year | N/A | $11.65 |
| Revenue Next Year | $934.41 | $4.77 |
| P/E Ratio | ★ N/A | $12.07 |
| Revenue Growth | N/A | ★ 9.64 |
| 52 Week Low | $1.61 | $27.91 |
| 52 Week High | $6.88 | $38.71 |
| Indicator | CMPX | UVSP |
|---|---|---|
| Relative Strength Index (RSI) | 19.32 | 66.93 |
| Support Level | N/A | $32.00 |
| Resistance Level | $3.74 | N/A |
| Average True Range (ATR) | 0.52 | 1.03 |
| MACD | -0.27 | 0.03 |
| Stochastic Oscillator | 1.91 | 72.51 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.